GSK plc ADR sell Morgan Stanley
Start price
14.01.26
/
50%
€43.20
Target price
14.01.27
-
Performance (%)
15.28%
Price
03.03.26
€49.20
Summary
This prediction is currently active. The prediction currently has a disappointing performance of 15.28%. This prediction currently runs until 14.01.27. The prediction end date can be changed by Morgan_Stanley at any time. Morgan_Stanley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| GSK plc ADR | -5.385% | -5.385% |
| iShares Core DAX® | -3.986% | -2.814% |
| iShares Nasdaq 100 | 0.345% | -0.748% |
| iShares Nikkei 225® | -3.853% | 4.229% |
| iShares S&P 500 | 0.298% | 0.379% |
Comments by Morgan_Stanley for this prediction
In the thread GSK plc ADR diskutieren
GSK (NYSE:GSK) had its "underweight" rating reaffirmed by analysts at Morgan Stanley.
Ratings data for GSK provided by MarketBeat